Literature DB >> 2168145

Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032).

P Canepari1, M Boaretti, M M Lleó, G Satta.   

Abstract

Daptomycin at the MIC allowed the cell mass increase of enterococcal strains and Bacillus subtilis to continue for 2 to 3 h at rates comparable to those of the controls. During this time the cell shape of the former changed to a rod configuration and that of the latter changed to long rods. In these bacteria, in which cell mass continued to increase, the MIC of daptomycin inhibited peptidoglycan synthesis by no more than 20% after 20 min of incubation and by roughly 50% after 2 h of incubation. Other macromolecules, such as DNA, RNA, and proteins, were only slightly affected. In contrast, incorporation of [14C]acetate into lipids was reduced by about 50% in the various strains after 20 min of treatment with daptomycin at the MIC. When the effect of the major lipid-containing polymers on synthesis was evaluated in detail, it was found that under conditions in which peptidoglycan and the other macromolecules mentioned above were inhibited only slightly (20%) and total lipid synthesis was inhibited by 50%, synthesis of teichoic and lipoteichoic acid was inhibited by 50 and 93%, respectively. Daptomycin was not found to enter the cytoplasm of either bacterial or mammalian cells. It bound, in the presence of calcium ions only, to whole bacterial cells, cell walls (both those that contained and those that did not contain membranes), and isolated membranes of bacterial and mammalian cells. Washing with EDTA removed daptomycin from all cells mentioned above and cell fractions except the bacterial membrane. It is concluded that lipoteichoic acid is most likely the primary target of daptomycin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168145      PMCID: PMC171788          DOI: 10.1128/AAC.34.6.1220

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

1.  Activity of LY146032 against Enterococci with and without high-level aminoglycoside resistance, including two penicillinase-producing strains.

Authors:  A R Wanger; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

2.  Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032.

Authors:  N E Allen; J N Hobbs; W E Alborn
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

3.  In vitro activity of a new cyclic lipopeptide antibiotic, LY146032, against gram-positive clinical bacteria.

Authors:  P Huovinen; P Kotilainen
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

4.  Biosynthesis of the peptidoglycan of bacterial cell walls. 8. Peptidoglycan transpeptidase and D-alanine carboxypeptidase: penicillin-sensitive enzymatic reaction in strains of Escherichia coli.

Authors:  K Izaki; M Matsuhashi; J L Strominger
Journal:  J Biol Chem       Date:  1968-06-10       Impact factor: 5.157

5.  Adherence of group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid.

Authors:  G Teti; F Tomasello; M S Chiofalo; G Orefici; P Mastroeni
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

6.  Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Lab Clin Med       Date:  1971-05

7.  Control of cell septation by lateral wall extension in a pH-conditional morphology mutant of Klebsiella pneumoniae.

Authors:  G Satta; P Canepari; G Botta; R Fontana
Journal:  J Bacteriol       Date:  1980-04       Impact factor: 3.490

8.  Streptococcus faecium mutants that are temperature sensitive for cell growth and show alterations in penicillin-binding proteins.

Authors:  P Canepari; M M Lleò; R Fontana; G Satta
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

9.  Comparative in vitro antibiotic resistance of surface-colonizing coagulase-negative staphylococci.

Authors:  A G Gristina; R A Jennings; P T Naylor; Q N Myrvik; L X Webb
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

10.  Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein.

Authors:  E H Beachey; I Ofek
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

View more
  43 in total

1.  Resistance studies with daptomycin.

Authors:  J A Silverman; N Oliver; T Andrew; T Li
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Population pharmacokinetics of daptomycin.

Authors:  Barry Dvorchik; Robert D Arbeit; Julia Chung; Susan Liu; William Knebel; Helen Kastrissios
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

3.  In vitro activity of daptomycin against gram-positive European clinical isolates with defined resistance determinants.

Authors:  Ad C Fluit; Franz-Josef Schmitz; Jan Verhoef; Dana Milatovic
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

Review 4.  Mechanisms of drug resistance: daptomycin resistance.

Authors:  Truc T Tran; Jose M Munita; Cesar A Arias
Journal:  Ann N Y Acad Sci       Date:  2015-10-23       Impact factor: 5.691

5.  Daptomycin disrupts membrane potential in growing Staphylococcus aureus.

Authors:  W E Alborn; N E Allen; D A Preston
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

6.  Effect of daptomycin on primary rat muscle cell cultures in vitro.

Authors:  Tatiana Y Kostrominova; Scott Coleman; Frederick B Oleson; John A Faulkner; Lisa M Larkin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-04-10       Impact factor: 2.416

Review 7.  Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci.

Authors:  William R Miller; Arnold S Bayer; Cesar A Arias
Journal:  Cold Spring Harb Perspect Med       Date:  2016-11-01       Impact factor: 6.915

8.  Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.

Authors:  Philippe Cottagnoud; Marc Pfister; Fernando Acosta; Marianne Cottagnoud; Lukas Flatz; Felix Kühn; Hans-Peter Müller; Armin Stucki
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16.

Authors:  Bruk Mensa; Gabriella L Howell; Richard Scott; William F DeGrado
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

10.  Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus.

Authors:  Angelika Gründling; Olaf Schneewind
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.